Article
Emerging roles and therapeutic implications of HDAC2 and IL-17A in steroid-resistant asthma
1 Jun 2023
Abstract excerpt
Steroid resistance represents a major clinical problem in the treatment of severe asthma, and therefore a better understanding of its pathogenesis is warranted. Recent studies indicated that histone deacetylase 2 (HDAC2) and interleukin 17A (IL-17A) play important roles in severe asthma. HDAC2 activity is reduced in patients with severe asthma and smoking-induced asthma, perhaps accounting for the amplified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
